Received Oct 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
a vial of the MMR (Priorix) vaccine in the box without its corresponding sterile diluent.; Inappropriate dose of vaccine administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: a vial of the MMR (Priorix) vaccine in the box without its corresponding sterile diluent.) and inappropriate dose of vaccine administered (Verbatim: Inappropriate dose of vaccine administered ). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-OCT-2025 The reporter worked for a doctor office. The reporter had a question regarding Priorix. They discovered a vial of the MMR (Priorix) vaccine in the box without its corresponding sterile diluent. The reporter reported that prior to being discovered, two patients received the Priorix vaccine, however, they were unable to determine which patient received the properly reconstituted vaccine and which may have received the one without the diluent. The reporter did not have patient information with by hand. The reporter knew product name was Priorix not a new box. The reporter was reaching out to ask the manufacture for guidance on what should be the next step.